WUXI BIO (02269.HK) -0.650 (-2.529%) Short selling $172.00M; Ratio 27.466% announced that Biologics Holdings, controlled by Chairman and Non-executive Director Ge Li, a major shareholder of the Company, entered into a Block Trade Agreement with the Placement Agent Morgan Stanley on June 14. The Agreement involves the placing of 82.94 million existing shares of the Company, representing approximately 2.04% of the Company's issued share capital, at a price of HKD26.6 per share, representing a 5% discount to its closing price of HKD28 last Friday (13th). The transaction is expected to cash in HKD2.206 billion.Upon completion of the Placing, Biologics Holdings' stake in WUXI BIO will decrease from approximately 14.36% to 12.32%, remaining a major shareholder of the company.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-18 12:25.)